Stefano Caruso
@Stecarus
Followers
181
Following
1K
Media
70
Statuses
460
Joined September 2011
💥Thrilled to see our paper on Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma (cHCC-CCA) by @Caldera60373705 et al. finally out in @JHepatology. A thread 🧵🪡 summarizing the main findings. 1/ @EASLnews
https://t.co/qV3sIYQ7bi
1
10
28
One year after its launch, ESAC announces its 1st Annual Meeting. 📅 May 7–8, 2026 📍 Politecnico di Milano (Via Bonardi 9, 20133 Milan) 📢 Call for abstracts open until Feb 3, 2026 For details, visit the conference's website https://t.co/H579kgRGE0 Registrations opening soon
0
5
9
🎓 New Webinar Series: Artificial Intelligence in Oncology 🤝 #HeCOG & @ESAC_cancerAI join forces for a monthly webinar series on how #AI is transforming #oncology. 🧠 Learn from leading experts, explore real-world clinical applications & the future of cancer care. 📅 Nov 4, 2025
0
2
8
📍 Cluj-Napoca, Romania. The European TANGERINE consortium, led by Dr. Víctor Moreno (@idibell_cat /@ICO_oncologia ), met to review progress on an AI tool that predicts immunotherapy response and toxicity in cancer patients. 🔬 A step forward in #PersonalizedMedicine, driven by
0
2
2
At #LiverCancerSummit, Stefano Caruso introduced the transformative potential of spatial omics in liver cancer research. This emerging field offers unprecedented insights into tumor heterogeneity, microenvironment interactions, and high-resolution biomarker identification. With
0
4
12
Thank you @canceropole for the invitation to discuss spatial transcriptomics today in Paris! Very nice presentations and discussions!
📅🎓Vous êtes nombreux aujourd'hui pour la journée "Transcriptomique spatiale pour l'étude du MET" coordonnée par le groupe MET du @canceropole ! 🎯Quelles sont les apports et les limites de cette techno innovante ? Les experts invités en discutent. 🔗 https://t.co/BsVKn77LnO
0
3
10
This week, we hosted another summer school of medical AI at @tudresden_de @Medizin_TUD - led by @GhaffariNarmin 🤩 with dozens of participants from research teams in 🇮🇹🇫🇷🇷🇴🇩🇪🇺🇸 & plenty of discussions, memes & new research ideas 🌟 Funded by 🇪🇺 via https://t.co/zeoIvcscDR
1
4
55
Thank you once again to all our attendees for making the ENSCCA/Precision-BTC-Network Joint Meeting an unforgettable event! Your energy and contributions made it truly special. Thank you Krakow for hosting us! 🇵🇱 Looking forward to our next gathering! #ENSCCA #PrecisionBTCNet
0
13
40
Artificial intelligence for BTC management. Such brilliant talks regarding the application in BTC of this powerful technology. @PrecisionBTCnet @UCPHAndersenLab @Stecarus @hannah_muti #LucaViganó #ensccaPrecisionBTCNetworkJointmeeting
0
3
12
Up next, Dr. Stefano Caruso @Stecarus dives into the integration of digital pathology and spatial genomics in liver cancer research and diagnostics at #PrecisionBTCNet #ENSCCA #Krakow2024. 🔬🇵🇱
0
3
11
What a fun session at @EASLedu @EASLnews #EASLcongress 2024 about "Research in the age of AI" in Milan 🇮🇹🇪🇺. Any biomedical researcher should be aware of current AI tools and develop a basic literacy. @tudresden_de @NCT_UCC_DD @NCT_HD @Medizin_TUD @uniklinik_hd
2
8
47
🚀 It's AI Day #EASL2024 designed by our AI Task Force https://t.co/AfWOoxhfJq 📅 🧠 Research in the Era of AI 🕰️ 08:30 - 09:45 🌟 Studio: AI Liver Taskforce 🕰️ 12:30 - 13:00 🤖 AI in Clinical Care 🕰️ 17:15 - 18:15 @EASLnews @aelsharkawy75 @AleksanderKrag @Caldera60373705
5
12
39
Some personal news: I’ve secured a permanent research position at @Inserm so I'll be able to continue working with this happy bunch of the FunGeST team in the wonderful @CRCordeliers ! Stay tuned for scientific updates on the genomics of pediatric and adult liver cancer!
2
1
12
Recently published: @jnkath @Caldera60373705 @Stecarus @GhaffariNarmin @QingheZeng use #DeepLearning to re-classify combined hepatocellular-cholangiocarcinomas using histopathology #LiverCancer #CancerResearch @NatResCancer
nature.com
Nature Communications - Combined hepatocellular-cholangiocarcinomas (cHCC-CCA) are challenging to diagnose, as they exhibit features of hepatocellular carcinoma (HCC) and intrahepatic...
0
10
24
Don’t hesitate to register for this free event later today!! We’ll discuss the challenges of Molecular Tumor Boards for Hepatocellular Carcinoma #LiverTwitter
⏰Don't forget: Tonight 18:00 CET the EASL Molecular Tumour Board will discuss why such board is important for HCC cases and the development of targeted therapy. 👍 Free registration https://t.co/BxxILrgYYm 🗣️ @GABOUALFA,Tim Meyer, @TZ_Hirsch
#livertwitter, @EASLnews @NaultJc
1
4
5
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study - The Lancet Oncology by @Caldera60373705 !
1
9
36
If you want to know what is hidden behind @LongPan61162464, go see his poster at the #ILCA23 in Amsterdam!! @Stecarus @CRCordeliers
1
7
15
Our last work "Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab" was just released in journal of hepatology @JHepatology @CRCordeliers @Zucmanrossi
https://t.co/utcwou98yP
1
14
44
It was a pleasure having you here at @UPECactus and thank you again for making these challenging topics so simple!
Had a blast in the past 3 days participating as a speaker in the AI in Pathology course at Henri Mondor @Caldera60373705 @Stecarus in Paris together with our team @EKFZdigital. Thank you to all participating pathologists - it was a great atmosphere with energy and curiousity! 🤩
0
0
12
Two-year #postdoc position open: Join to Our Group #Hepatology Lab at CIMA in Pamplona. Investigate #Liver Cancer and unveil the #Epigenetic mechanisms involved. Collaborate with Leaders in #liverTumors and #Immunotherapies. Contact by DM. RT appreciated.
1
21
39